Related Experiment Video
Updated: Apr 18, 2026

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
Published on: September 12, 2016
Multiple sclerosis in 2014. Progress in MS--classification, mechanisms and treatment.
1Division of Neurology, Department of Medicine, St. Michael's Hospital, University of Toronto, 30 Bond Street, Toronto, ON M5B 1W8, Canada.
In 2014, multiple sclerosis (MS) research saw significant advances in treatments, classification, and understanding disease mechanisms, especially for progressive MS. These findings enhance our comprehension of this complex neurological condition.
Area of Science:
- Neurology
- Immunology
- Clinical Research
Background:
- Multiple sclerosis (MS) is a chronic, demyelinating disease of the central nervous system.
- Understanding the diverse mechanisms and progression of MS remains a critical challenge.
- Recent research has focused on improving therapeutic strategies and disease management.
Purpose of the Study:
- To review and synthesize key scientific advancements in multiple sclerosis research during 2014.
- To highlight progress in understanding disease mechanisms, classification, and risk management.
- To emphasize breakthroughs in the treatment of progressive forms of MS.
Main Methods:
- Literature review of peer-reviewed publications from 2014.
- Synthesis of findings across therapeutic, mechanistic, and epidemiological studies.
- Focus on studies reporting significant progress in progressive multiple sclerosis.
Main Results:
- Notable advancements were made in therapeutic interventions for multiple sclerosis.
- New insights into the underlying mechanisms of MS pathogenesis were reported.
- Significant progress was observed in the management and understanding of progressive MS phenotypes.
Conclusions:
- The year 2014 marked substantial progress in multiple sclerosis research.
- Findings contribute to a more comprehensive understanding of MS, particularly its progressive forms.
- Continued research is essential for developing more effective treatments and improving patient outcomes.
More Related Videos
06:19Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis
Published on: September 9, 2022
08:47Induction of Experimental Autoimmune Encephalomyelitis in Mice and Evaluation of the Disease-dependent Distribution of Immune Cells in Various Tissues
Published on: May 8, 2016
Related Concept Videos
Multiple Sclerosis l: Introduction
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
Myasthenia Gravis ll: Pathophysiology
Parkinson's Disease: Overview
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune...
Classification of Skeletal Muscle Relaxants
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...